Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0LI1C
|
||||
Former ID |
DNC011182
|
||||
Drug Name |
NITD609
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Malaria [ICD10:B54] | Phase 2 | [549327] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H14Cl2FN3O
|
||||
Canonical SMILES |
CC1CC2=C(C3(N1)C4=C(C=CC(=C4)Cl)NC3=O)NC5=CC(=C(C=C25)F<br />)Cl
|
||||
InChI |
1S/C19H14Cl2FN3O/c1-8-4-11-10-6-14(22)13(21)7-16(10)23-17(11)19(25-8)12-5-9(20)2-3-15(12)24-18(19)26/h2-3,5-8,23,25H,4H2,1H3,(H,24,26)/t8-,19+/m0/s1
|
||||
InChIKey |
CKLPLPZSUQEDRT-WPCRTTGESA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [531146] | |
Potassium voltage-gated channel subfamily H member 2 | Target Info | Inhibitor | [531146] | ||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.